Psyence Biomedical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PBM and other ETFs, options, and stocks.

About PBM

Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. 

CEO
Jody Aufrichtig
CEOJody Aufrichtig
Employees
12
Employees12
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
2021
Founded2021
Employees
12
Employees12

PBM Key Statistics

Market cap
2.59M
Market cap2.59M
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
Dividend yield
Average volume
410.44K
Average volume410.44K
High today
$2.57
High today$2.57
Low today
$2.50
Low today$2.50
Open price
$2.57
Open price$2.57
Volume
1.90K
Volume1.90K
52 Week high
$74.94
52 Week high$74.94
52 Week low
$1.92
52 Week low$1.92

Stock Snapshot

Psyence Biomedical(PBM) stock is priced at $2.53, giving the company a market capitalization of 2.59M. It carries a P/E multiple of -0.03.

As of 2026-03-05, Psyence Biomedical(PBM) stock has fluctuated between $2.50 and $2.57. The current price stands at $2.53, placing the stock +1.2% above today's low and -1.6% off the high.

Psyence Biomedical(PBM) shares are trading with a volume of 1.9K, against a daily average of 410.44K.

During the past year, Psyence Biomedical(PBM) stock moved between $1.92 at its lowest and $74.94 at its peak.

During the past year, Psyence Biomedical(PBM) stock moved between $1.92 at its lowest and $74.94 at its peak.

PBM News

TipRanks 2d
Psyence Biomedical announces export of psilocybin to Australia

Psyence Biomedical (PBM) announced the export of fully GMP-compliant manufactured psilocybin product NPX-5 to Australia. The product was manufactured at the Psy...

TipRanks 3d
Psyence Biomedical Finalizes PsyLabs Share Swap, Settlement-Linked Loan and Board Changes

Psyence Biomedical ( (PBM) ) just unveiled an update. On February 9, 2026, Psyence Biomedical’s subsidiary Psyence Biomed II Corp. extended a US$251,110 short-...

People also own

Based on the portfolios of people who own PBM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.